Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sugentech Inc. (253840:KRX), powered by AI.
Sugentech Inc. is currently trading at ₩6,760. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sugentech Inc. on Alpha Lenz.
Sugentech Inc.'s P/E ratio is -6.8.
“Sugentech Inc. trades at a P/E of -6.8 (undervalued) with modest ROE of -14.5%.”
Ask for details →Sugentech Inc. is a biotech company specializing in the development and production of diagnostic solutions. Its primary function is to innovate in the field of medical diagnostics, providing tools that assist in the early detection and monitoring of various health conditions. Sugentech Inc. focuses on sectors such as infectious diseases, cancer detection, and personalized medicine, offering products that utilize advanced technologies like biosensors and lab-on-a-chip systems. These advancements are pivotal in improving patient outcomes through more accurate and timely diagnostic results. The company plays a significant role in the healthcare market, contributing to the global effort toward more efficient disease management and personalized patient care. Headquartered in South Korea, Sugentech Inc. leverages its expertise to expand its presence in both domestic and international healthcare markets, addressing the growing demand for reliable and innovative diagnostic solutions.
“Sugentech Inc. trades at a P/E of -6.8 (undervalued) with modest ROE of -14.5%.”
Ask for details →Sugentech Inc. (ticker: 253840) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 144 employees. Market cap is $113.2B.
The current price is ₩6,760 with a P/E ratio of -6.8x and P/B of 1.06x.
ROE is -14.50% and operating margin is -218.10%. Annual revenue is $10.1B.